SCHEDULE: Vanguard Group Reports Zero Elanco Stake Post-Realignment

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Elanco Animal Health Inc. following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 6 to Schedule 13G regarding its beneficial ownership in Elanco Animal Health Inc. common stock.
• As of the filing, The Vanguard Group reports 0% beneficial ownership of Elanco Animal Health Inc. common stock.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these disaggregated subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral for Elanco Animal Health Inc., as it primarily concerns an administrative change in The Vanguard Group's internal reporting structure rather than a change in investment thesis or company performance.

Future Outlook

The filing does not provide forward-looking statements or guidance for Elanco Animal Health Inc. It primarily details a change in The Vanguard Group's reporting structure.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment.
• Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that this filing reflects an internal operational change within The Vanguard Group, a major institutional investor, rather than a direct investment decision regarding Elanco Animal Health Inc. Such realignments are common among large asset managers to optimize reporting and compliance, and do not necessarily indicate a change in overall institutional sentiment towards Elanco within Vanguard's broader family of funds.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure for changes in beneficial ownership, specifically an amendment to a Schedule 13G.
• The disaggregation of reporting by large asset managers like Vanguard is a recognized practice under SEC guidance (Release No. 34-39538), allowing for more granular reporting by distinct investment entities within a larger group.
• Similar reporting changes have been observed with other large institutional investors adjusting their internal structures for compliance and operational efficiency, such as BlackRock or State Street, when reorganizing their fund families or advisory services.

Stakeholder Impact

• Shareholders of Elanco Animal Health Inc. may observe a change in the reported institutional ownership by The Vanguard Group, though the underlying holdings by Vanguard's broader family of funds may remain consistent, just reported by different entities.
• The Vanguard Group's internal stakeholders are impacted by the realignment of reporting responsibilities, requiring adjustments in compliance and disclosure processes.

Next Steps

• Vanguard's subsidiaries or business divisions will report their beneficial ownership of Elanco Animal Health Inc. separately in future filings.

Key Dates

Keywords

Elanco Animal Health Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Ownership, SEC Filing, Common Stock, Investment Management, Portfolio Realignment